

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58188665 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.58188665 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25368307 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25368307 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.81659058 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.42873562 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.14244517 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.14244517 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.14244517 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.01205709 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.94600136 |
| 12 | detection of other organism (GO:0098543) | 5.87806504 |
| 13 | detection of bacterium (GO:0016045) | 5.86096462 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.77871709 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.74039079 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.72565971 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.72435395 |
| 18 | urea metabolic process (GO:0019627) | 5.69935815 |
| 19 | urea cycle (GO:0000050) | 5.69935815 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.66586092 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62301413 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.53371983 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.52407522 |
| 24 | response to peptidoglycan (GO:0032494) | 5.50781489 |
| 25 | protein carboxylation (GO:0018214) | 5.47322991 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.47322991 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.47022135 |
| 28 | negative regulation of cell killing (GO:0031342) | 5.47022135 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.45706027 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.45706027 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 5.45706027 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 5.45706027 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 5.45706027 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.45706027 |
| 35 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.42465192 |
| 36 | regulation of protein activation cascade (GO:2000257) | 5.42348262 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 5.31195932 |
| 38 | cysteine metabolic process (GO:0006534) | 5.28613599 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 5.23749448 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.20471829 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 5.11916802 |
| 42 | bile acid metabolic process (GO:0008206) | 5.10988999 |
| 43 | regulation of complement activation (GO:0030449) | 5.05423099 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 4.98295619 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.98004947 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 4.97623552 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.95046157 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.94606250 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.87751561 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.85479675 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 4.85479675 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.85479675 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84528003 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.82400367 |
| 55 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.74139541 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.72300891 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69166924 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.63409456 |
| 59 | phospholipid efflux (GO:0033700) | 4.63054317 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.62572001 |
| 61 | acylglycerol homeostasis (GO:0055090) | 4.62572001 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.61521539 |
| 63 | negative regulation of sterol transport (GO:0032372) | 4.61521539 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 4.59323127 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.58248867 |
| 66 | lysine catabolic process (GO:0006554) | 4.52664271 |
| 67 | lysine metabolic process (GO:0006553) | 4.52664271 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.50693394 |
| 69 | immunoglobulin mediated immune response (GO:0016064) | 4.49505758 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.44742658 |
| 71 | detection of external biotic stimulus (GO:0098581) | 4.43208914 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.42237659 |
| 73 | glycine metabolic process (GO:0006544) | 4.40592214 |
| 74 | macrophage activation involved in immune response (GO:0002281) | 4.38178610 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.35813794 |
| 76 | indolalkylamine metabolic process (GO:0006586) | 4.34648328 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.33778137 |
| 78 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.33633404 |
| 79 | cholesterol efflux (GO:0033344) | 4.29424794 |
| 80 | amine catabolic process (GO:0009310) | 4.25711217 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 4.25711217 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 4.25492390 |
| 83 | glutamate metabolic process (GO:0006536) | 4.23067482 |
| 84 | cellular glucuronidation (GO:0052695) | 4.21892357 |
| 85 | response to interleukin-15 (GO:0070672) | 4.18791043 |
| 86 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.17543454 |
| 87 | cellular response to interleukin-15 (GO:0071350) | 4.17333731 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 4.17129721 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 4.14223666 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 4.13576095 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 4.12724708 |
| 92 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.12365771 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10040394 |
| 94 | fibrinolysis (GO:0042730) | 4.08914802 |
| 95 | plasma lipoprotein particle assembly (GO:0034377) | 4.06451091 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 4.06187164 |
| 97 | arginine metabolic process (GO:0006525) | 4.04237162 |
| 98 | cellular modified amino acid catabolic process (GO:0042219) | 4.03223562 |
| 99 | ethanol oxidation (GO:0006069) | 4.01321493 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00924664 |
| 101 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.97909554 |
| 102 | detection of biotic stimulus (GO:0009595) | 3.97127132 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 3.96950777 |
| 104 | response to muramyl dipeptide (GO:0032495) | 3.96746754 |
| 105 | drug catabolic process (GO:0042737) | 3.95922355 |
| 106 | aldehyde catabolic process (GO:0046185) | 3.95855917 |
| 107 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95610452 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91096136 |
| 109 | ketone body metabolic process (GO:1902224) | 3.90124635 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88032830 |
| 111 | complement activation (GO:0006956) | 3.82400624 |
| 112 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82199889 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82199889 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.81771233 |
| 115 | protein activation cascade (GO:0072376) | 3.81538482 |
| 116 | cofactor catabolic process (GO:0051187) | 3.81486499 |
| 117 | complement activation, classical pathway (GO:0006958) | 3.81290138 |
| 118 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.80843984 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.79048458 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.77726156 |
| 121 | cholesterol homeostasis (GO:0042632) | 3.76226069 |
| 122 | phospholipid homeostasis (GO:0055091) | 3.75161076 |
| 123 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.74861841 |
| 124 | glucuronate metabolic process (GO:0019585) | 3.74303119 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.74303119 |
| 126 | microglial cell activation (GO:0001774) | 3.74154958 |
| 127 | organic acid catabolic process (GO:0016054) | 3.72742109 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 3.72742109 |
| 129 | sterol homeostasis (GO:0055092) | 3.69935197 |
| 130 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69195366 |
| 131 | plasma lipoprotein particle organization (GO:0071827) | 3.68495797 |
| 132 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66586659 |
| 133 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.65959601 |
| 134 | protein-lipid complex assembly (GO:0065005) | 3.64032488 |
| 135 | short-chain fatty acid metabolic process (GO:0046459) | 3.63754198 |
| 136 | opsonization (GO:0008228) | 3.62199501 |
| 137 | acetyl-CoA metabolic process (GO:0006084) | 3.61922405 |
| 138 | acute-phase response (GO:0006953) | 3.61629924 |
| 139 | cytolysis (GO:0019835) | 3.60461241 |
| 140 | regulation of cholesterol homeostasis (GO:2000188) | 3.60128515 |
| 141 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.59130123 |
| 142 | response to host immune response (GO:0052572) | 3.59130123 |
| 143 | regulation of mast cell activation (GO:0033003) | 3.58960594 |
| 144 | B cell mediated immunity (GO:0019724) | 3.57660718 |
| 145 | regulation of leukocyte degranulation (GO:0043300) | 3.56278898 |
| 146 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.54085901 |
| 147 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.52972566 |
| 148 | negative thymic T cell selection (GO:0045060) | 3.48546140 |
| 149 | detection of molecule of bacterial origin (GO:0032490) | 3.47757548 |
| 150 | regulation of antigen processing and presentation (GO:0002577) | 3.42865338 |
| 151 | positive regulation of interleukin-17 production (GO:0032740) | 3.40831726 |
| 152 | response to type I interferon (GO:0034340) | 3.39493290 |
| 153 | type I interferon signaling pathway (GO:0060337) | 3.39144872 |
| 154 | cellular response to type I interferon (GO:0071357) | 3.39144872 |
| 155 | neutrophil activation (GO:0042119) | 3.37892610 |
| 156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37737203 |
| 157 | response to host (GO:0075136) | 3.37737203 |
| 158 | response to host defenses (GO:0052200) | 3.37737203 |
| 159 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.36967479 |
| 160 | positive regulation of mast cell degranulation (GO:0043306) | 3.36967479 |
| 161 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35803697 |
| 162 | positive regulation of type 2 immune response (GO:0002830) | 3.34150162 |
| 163 | regulation of platelet aggregation (GO:0090330) | 3.32520797 |
| 164 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31511175 |
| 165 | T cell selection (GO:0045058) | 3.28487070 |
| 166 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28466958 |
| 167 | negative T cell selection (GO:0043383) | 3.25272427 |
| 168 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.23183203 |
| 169 | myeloid cell activation involved in immune response (GO:0002275) | 3.22877615 |
| 170 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.20208933 |
| 171 | mannose metabolic process (GO:0006013) | 3.19786890 |
| 172 | macrophage activation (GO:0042116) | 3.18958720 |
| 173 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.17494834 |
| 174 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.16558354 |
| 175 | positive thymic T cell selection (GO:0045059) | 3.13201162 |
| 176 | granulocyte activation (GO:0036230) | 3.10482720 |
| 177 | regulation of tolerance induction (GO:0002643) | 3.09545151 |
| 178 | regulation of regulated secretory pathway (GO:1903305) | 3.07578090 |
| 179 | myeloid dendritic cell activation (GO:0001773) | 3.05977096 |
| 180 | myeloid dendritic cell differentiation (GO:0043011) | 3.04974535 |
| 181 | positive regulation of B cell differentiation (GO:0045579) | 3.02648596 |
| 182 | defense response to protozoan (GO:0042832) | 3.02235792 |
| 183 | tolerance induction (GO:0002507) | 3.00691792 |
| 184 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99504059 |
| 185 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98115839 |
| 186 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.98037433 |
| 187 | regulation of interleukin-17 production (GO:0032660) | 2.96430735 |
| 188 | regulation of T cell tolerance induction (GO:0002664) | 2.94421981 |
| 189 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.91061586 |
| 190 | leukocyte aggregation (GO:0070486) | 2.90458259 |
| 191 | B cell receptor signaling pathway (GO:0050853) | 2.88946947 |
| 192 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.85013716 |
| 193 | Peyers patch development (GO:0048541) | 2.85013716 |
| 194 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.83649810 |
| 195 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83010619 |
| 196 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.81483419 |
| 197 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.79855319 |
| 198 | germinal center formation (GO:0002467) | 2.79718922 |
| 199 | T cell migration (GO:0072678) | 2.79321080 |
| 200 | regulation of type 2 immune response (GO:0002828) | 2.79308213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40375492 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18516796 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.04144747 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50939369 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.29710795 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.17802797 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.85059332 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06375290 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.03619396 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.99850588 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.59405620 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43030588 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21449914 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06820875 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.99921625 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.99653351 |
| 17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93245597 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.63021113 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.61468621 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61384580 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.52388581 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.50081868 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.49395039 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48125600 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42961396 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36946108 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.22458779 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20459302 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.20105343 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 2.20037554 |
| 31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.16895670 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.12506592 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08595493 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06745443 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06549316 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.05161346 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0035341 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97207883 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95503794 |
| 40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95327838 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93960767 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.93303985 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91798110 |
| 44 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89893788 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85246127 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85049950 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82502543 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82433894 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77020832 |
| 50 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.75819344 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67337177 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65889678 |
| 53 | * MYB_26560356_Chip-Seq_TH1_Human | 1.64677559 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63462340 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.63185246 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61938958 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60726571 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.58988877 |
| 59 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58473790 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.58172910 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53390822 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53017327 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45787143 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44834219 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44347396 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44278816 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43462966 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42717635 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40848737 |
| 70 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39607478 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33148706 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28524262 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28006173 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24709606 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22860423 |
| 76 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19753249 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19640989 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19638757 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19118257 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18482590 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17793723 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17737391 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17646302 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16321580 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15639985 |
| 86 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14406195 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14038755 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13896451 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09950154 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09790354 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09138127 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05101075 |
| 93 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.04743536 |
| 94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03562063 |
| 95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03540570 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01709565 |
| 97 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01286758 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00604414 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98452528 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96205053 |
| 101 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94753835 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94672731 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94303469 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.92065438 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91911608 |
| 106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91061670 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89551344 |
| 108 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88871054 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88748169 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88059888 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.87762728 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87212184 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86572057 |
| 114 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84733111 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83607401 |
| 116 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83310375 |
| 117 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.82726155 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81388403 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79809819 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79232866 |
| 121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78565057 |
| 122 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76266729 |
| 123 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75502993 |
| 124 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75206593 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74525840 |
| 126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73092568 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73037537 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72768947 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70011133 |
| 130 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66179392 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65946621 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65294402 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.64185544 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64108671 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64108671 |
| 136 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63500539 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62769757 |
| 138 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62599089 |
| 139 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61117216 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59965090 |
| 141 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58308774 |
| 142 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56705226 |
| 143 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54680205 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54371352 |
| 145 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.53430577 |
| 146 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52514025 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52055646 |
| 148 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51008980 |
| 149 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50847909 |
| 150 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50477402 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48779170 |
| 152 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48473718 |
| 153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48415829 |
| 154 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47766922 |
| 155 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47315929 |
| 156 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46257156 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45767770 |
| 158 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.45664524 |
| 159 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44453270 |
| 160 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43585504 |
| 161 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43411908 |
| 162 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43245891 |
| 163 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43209988 |
| 164 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41322046 |
| 165 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41132346 |
| 166 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40683108 |
| 167 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.40414150 |
| 168 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40316303 |
| 169 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39970637 |
| 170 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.39795610 |
| 171 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39542699 |
| 172 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39516750 |
| 173 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39458339 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38973649 |
| 175 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38140862 |
| 176 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37646635 |
| 177 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36528808 |
| 178 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36480082 |
| 179 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36284083 |
| 180 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35279338 |
| 181 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33395084 |
| 182 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33391543 |
| 183 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.32579048 |
| 184 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32564173 |
| 185 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.32542278 |
| 186 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32175006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.32894898 |
| 2 | MP0005360_urolithiasis | 7.53544731 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.45556630 |
| 4 | MP0005365_abnormal_bile_salt | 6.14930954 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.17913681 |
| 6 | MP0001835_abnormal_antigen_presentation | 4.62615178 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.21351859 |
| 8 | MP0003303_peritoneal_inflammation | 3.94736454 |
| 9 | MP0003252_abnormal_bile_duct | 3.88795001 |
| 10 | MP0005671_abnormal_response_to | 3.88577177 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.60948755 |
| 12 | MP0009840_abnormal_foam_cell | 3.35561255 |
| 13 | MP0005083_abnormal_biliary_tract | 3.12646344 |
| 14 | MP0003195_calcinosis | 2.82074054 |
| 15 | MP0001790_abnormal_immune_system | 2.77765353 |
| 16 | MP0005387_immune_system_phenotype | 2.77765353 |
| 17 | MP0005332_abnormal_amino_acid | 2.75027163 |
| 18 | MP0001800_abnormal_humoral_immune | 2.70315201 |
| 19 | MP0002419_abnormal_innate_immunity | 2.68421692 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.60987933 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.60985541 |
| 22 | MP0005025_abnormal_response_to | 2.59623932 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.57020887 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.43911140 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.42195876 |
| 26 | MP0000685_abnormal_immune_system | 2.40643534 |
| 27 | MP0002723_abnormal_immune_serum | 2.40338714 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.28481793 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.22517315 |
| 30 | MP0001819_abnormal_immune_cell | 2.21960279 |
| 31 | MP0009785_altered_susceptibility_to | 2.20977469 |
| 32 | MP0000609_abnormal_liver_physiology | 2.16946254 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 2.14035499 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 2.10288895 |
| 35 | MP0010155_abnormal_intestine_physiology | 2.08571887 |
| 36 | MP0001533_abnormal_skeleton_physiology | 2.04793158 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.97580323 |
| 38 | MP0008260_abnormal_autophagy | 1.95781916 |
| 39 | MP0003868_abnormal_feces_composition | 1.92241204 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.91105000 |
| 41 | MP0002398_abnormal_bone_marrow | 1.89608794 |
| 42 | MP0003866_abnormal_defecation | 1.85721018 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.82575759 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.82391733 |
| 45 | MP0003828_pulmonary_edema | 1.80760795 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.77942291 |
| 47 | MP0000716_abnormal_immune_system | 1.76863088 |
| 48 | MP0002405_respiratory_system_inflammati | 1.70903881 |
| 49 | MP0004510_myositis | 1.70334433 |
| 50 | MP0001764_abnormal_homeostasis | 1.65107115 |
| 51 | MP0009278_abnormal_bone_marrow | 1.61536711 |
| 52 | MP0003878_abnormal_ear_physiology | 1.59946736 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.59946736 |
| 54 | MP0009697_abnormal_copulation | 1.59855391 |
| 55 | MP0008004_abnormal_stomach_pH | 1.56634919 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56316668 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.54173412 |
| 58 | MP0002722_abnormal_immune_system | 1.52661915 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.49644137 |
| 60 | MP0004947_skin_inflammation | 1.49576169 |
| 61 | MP0002166_altered_tumor_susceptibility | 1.48831229 |
| 62 | MP0002429_abnormal_blood_cell | 1.47321187 |
| 63 | MP0005451_abnormal_body_composition | 1.44471708 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.44177762 |
| 65 | MP0001851_eye_inflammation | 1.40025739 |
| 66 | MP0003011_delayed_dark_adaptation | 1.38500937 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.36664147 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.36664147 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.32684267 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.30961853 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.29486659 |
| 72 | MP0003186_abnormal_redox_activity | 1.24458977 |
| 73 | MP0002102_abnormal_ear_morphology | 1.24185914 |
| 74 | MP0005310_abnormal_salivary_gland | 1.22389876 |
| 75 | MP0009643_abnormal_urine_homeostasis | 1.21631363 |
| 76 | MP0000598_abnormal_liver_morphology | 1.17933396 |
| 77 | MP0000858_altered_metastatic_potential | 1.17525458 |
| 78 | MP0003705_abnormal_hypodermis_morpholog | 1.17246204 |
| 79 | MP0005647_abnormal_sex_gland | 1.13582756 |
| 80 | MP0000604_amyloidosis | 1.13201338 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.09461935 |
| 82 | MP0009764_decreased_sensitivity_to | 1.07567100 |
| 83 | MP0002254_reproductive_system_inflammat | 1.06199567 |
| 84 | MP0009763_increased_sensitivity_to | 1.04800889 |
| 85 | MP0010368_abnormal_lymphatic_system | 1.02049063 |
| 86 | MP0005409_darkened_coat_color | 1.01537314 |
| 87 | MP0002653_abnormal_ependyma_morphology | 1.00612564 |
| 88 | MP0003879_abnormal_hair_cell | 0.97873690 |
| 89 | MP0001663_abnormal_digestive_system | 0.92859389 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.91275586 |
| 91 | MP0008469_abnormal_protein_level | 0.90242189 |
| 92 | MP0003091_abnormal_cell_migration | 0.89542087 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.88561042 |
| 94 | MP0000343_altered_response_to | 0.87428310 |
| 95 | MP0009642_abnormal_blood_homeostasis | 0.87421053 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.87239187 |
| 97 | MP0005390_skeleton_phenotype | 0.87166746 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.85497521 |
| 99 | MP0002006_tumorigenesis | 0.83833985 |
| 100 | MP0005408_hypopigmentation | 0.83486448 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.79809278 |
| 102 | MP0009765_abnormal_xenobiotic_induced | 0.79289619 |
| 103 | MP0005376_homeostasis/metabolism_phenot | 0.78868553 |
| 104 | MP0000490_abnormal_crypts_of | 0.78426678 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.77492286 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.77190913 |
| 107 | MP0005670_abnormal_white_adipose | 0.77075098 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.73022571 |
| 109 | MP0002971_abnormal_brown_adipose | 0.72111457 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.72015772 |
| 111 | MP0003045_fibrosis | 0.71726700 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.71328458 |
| 113 | MP0003690_abnormal_glial_cell | 0.70392118 |
| 114 | MP0001661_extended_life_span | 0.69669535 |
| 115 | MP0004130_abnormal_muscle_cell | 0.68686156 |
| 116 | MP0001958_emphysema | 0.68641758 |
| 117 | MP0005334_abnormal_fat_pad | 0.68220637 |
| 118 | MP0005535_abnormal_body_temperature | 0.65820823 |
| 119 | MP0009053_abnormal_anal_canal | 0.65710237 |
| 120 | MP0001873_stomach_inflammation | 0.65224900 |
| 121 | MP0003329_amyloid_beta_deposits | 0.64672332 |
| 122 | MP0001849_ear_inflammation | 0.63257303 |
| 123 | MP0003448_altered_tumor_morphology | 0.63042357 |
| 124 | MP0005266_abnormal_metabolism | 0.62448779 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.61869969 |
| 126 | MP0004808_abnormal_hematopoietic_stem | 0.60018870 |
| 127 | MP0003795_abnormal_bone_structure | 0.59923642 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.59451584 |
| 129 | MP0005464_abnormal_platelet_physiology | 0.57790138 |
| 130 | MP0002933_joint_inflammation | 0.57471668 |
| 131 | MP0001756_abnormal_urination | 0.57394585 |
| 132 | MP0005448_abnormal_energy_balance | 0.55709892 |
| 133 | MP0006035_abnormal_mitochondrial_morpho | 0.54877813 |
| 134 | MP0002822_catalepsy | 0.48941435 |
| 135 | MP0005395_other_phenotype | 0.48758776 |
| 136 | MP0003638_abnormal_response/metabolism_ | 0.47513987 |
| 137 | MP0003436_decreased_susceptibility_to | 0.47016583 |
| 138 | MP0008874_decreased_physiological_sensi | 0.46575272 |
| 139 | MP0003718_maternal_effect | 0.45456991 |
| 140 | MP0003724_increased_susceptibility_to | 0.45006044 |
| 141 | MP0008873_increased_physiological_sensi | 0.44795281 |
| 142 | MP0002136_abnormal_kidney_physiology | 0.44737616 |
| 143 | MP0003075_altered_response_to | 0.42945674 |
| 144 | MP0002928_abnormal_bile_duct | 0.42869183 |
| 145 | MP0004782_abnormal_surfactant_physiolog | 0.41115059 |
| 146 | MP0002837_dystrophic_cardiac_calcinosis | 0.40894892 |
| 147 | MP0003953_abnormal_hormone_level | 0.39751532 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.39477546 |
| 149 | MP0005166_decreased_susceptibility_to | 0.38279814 |
| 150 | MP0008872_abnormal_physiological_respon | 0.37550481 |
| 151 | MP0009672_abnormal_birth_weight | 0.35565199 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.34954710 |
| 153 | MP0000249_abnormal_blood_vessel | 0.34395321 |
| 154 | MP0006082_CNS_inflammation | 0.34238824 |
| 155 | MP0004381_abnormal_hair_follicle | 0.34038485 |
| 156 | MP0004883_abnormal_blood_vessel | 0.33530959 |
| 157 | MP0000579_abnormal_nail_morphology | 0.33394159 |
| 158 | MP0001243_abnormal_dermal_layer | 0.32552688 |
| 159 | MP0009115_abnormal_fat_cell | 0.32214338 |
| 160 | MP0000230_abnormal_systemic_arterial | 0.30930240 |
| 161 | MP0001853_heart_inflammation | 0.30837365 |
| 162 | MP0002168_other_aberrant_phenotype | 0.30400122 |
| 163 | MP0009384_cardiac_valve_regurgitation | 0.30334650 |
| 164 | MP0002970_abnormal_white_adipose | 0.29887949 |
| 165 | MP0002796_impaired_skin_barrier | 0.29426423 |
| 166 | MP0001845_abnormal_inflammatory_respons | 0.29110081 |
| 167 | MP0001881_abnormal_mammary_gland | 0.27562922 |
| 168 | MP0005164_abnormal_response_to | 0.26289956 |
| 169 | MP0002090_abnormal_vision | 0.24635658 |
| 170 | MP0002132_abnormal_respiratory_system | 0.23910692 |
| 171 | MP0005058_abnormal_lysosome_morphology | 0.23339332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.56045346 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.41302978 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.30163164 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.72731287 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69141719 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.47091651 |
| 7 | Xanthomatosis (HP:0000991) | 6.29284169 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.65962038 |
| 9 | Complement deficiency (HP:0004431) | 5.42173593 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.93015783 |
| 11 | Joint hemorrhage (HP:0005261) | 4.92795804 |
| 12 | Prolonged bleeding time (HP:0003010) | 4.89683426 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.85036784 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 4.79624706 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.79624706 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.69619151 |
| 17 | Recurrent abscess formation (HP:0002722) | 4.61881099 |
| 18 | Hyperammonemia (HP:0001987) | 4.59040829 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.56762359 |
| 20 | Myositis (HP:0100614) | 4.54436887 |
| 21 | Recurrent bacterial skin infections (HP:0005406) | 4.53979627 |
| 22 | Epidermoid cyst (HP:0200040) | 4.51756297 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.43983738 |
| 24 | Recurrent fungal infections (HP:0002841) | 4.40822220 |
| 25 | Hyperglycinemia (HP:0002154) | 4.37068465 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.36997905 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 4.32448727 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 4.26563621 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25096267 |
| 30 | Ketosis (HP:0001946) | 4.22598553 |
| 31 | Purpura (HP:0000979) | 4.17727882 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 4.15610980 |
| 33 | Optic neuritis (HP:0100653) | 4.15610980 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14530392 |
| 35 | Orchitis (HP:0100796) | 4.13160529 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11620924 |
| 37 | Fat malabsorption (HP:0002630) | 4.09825976 |
| 38 | Recurrent skin infections (HP:0001581) | 4.00460947 |
| 39 | Abnormality of complement system (HP:0005339) | 3.96740568 |
| 40 | Colitis (HP:0002583) | 3.94631379 |
| 41 | Meningitis (HP:0001287) | 3.87030136 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86959142 |
| 43 | Abnormal platelet volume (HP:0011876) | 3.86645814 |
| 44 | Petechiae (HP:0000967) | 3.85852406 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 3.85052019 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85052019 |
| 47 | Hyperglycinuria (HP:0003108) | 3.84963740 |
| 48 | Encephalitis (HP:0002383) | 3.84535511 |
| 49 | Spontaneous hematomas (HP:0007420) | 3.84050348 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83543761 |
| 51 | Hypoglycemic coma (HP:0001325) | 3.82216188 |
| 52 | Epistaxis (HP:0000421) | 3.77551401 |
| 53 | Recurrent viral infections (HP:0004429) | 3.76470792 |
| 54 | Hypercholesterolemia (HP:0003124) | 3.67503228 |
| 55 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66880072 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 3.63730556 |
| 57 | Inflammation of the large intestine (HP:0002037) | 3.60474116 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.55633171 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 3.54184914 |
| 60 | Increased IgE level (HP:0003212) | 3.48324043 |
| 61 | Increased mean platelet volume (HP:0011877) | 3.36773233 |
| 62 | Hyperbilirubinemia (HP:0002904) | 3.36539422 |
| 63 | Agammaglobulinemia (HP:0004432) | 3.32934599 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32662261 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 3.32141113 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30023606 |
| 67 | Obstructive lung disease (HP:0006536) | 3.30023606 |
| 68 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29132988 |
| 69 | Spontaneous abortion (HP:0005268) | 3.14477415 |
| 70 | Pulmonary infiltrates (HP:0002113) | 3.08688941 |
| 71 | Steatorrhea (HP:0002570) | 3.08464297 |
| 72 | Delayed CNS myelination (HP:0002188) | 3.06583734 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04247484 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 3.04037291 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 3.03632089 |
| 76 | Chest pain (HP:0100749) | 3.02597037 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.98909644 |
| 78 | Ketoacidosis (HP:0001993) | 2.97602456 |
| 79 | Vasculitis (HP:0002633) | 2.97398962 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.96197598 |
| 81 | Hemoptysis (HP:0002105) | 2.95895485 |
| 82 | Myocardial infarction (HP:0001658) | 2.95299818 |
| 83 | Stomatitis (HP:0010280) | 2.95200132 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 2.91877053 |
| 85 | Gingivitis (HP:0000230) | 2.85049244 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.84319058 |
| 87 | Systemic lupus erythematosus (HP:0002725) | 2.79891576 |
| 88 | Arterial thrombosis (HP:0004420) | 2.79275954 |
| 89 | Skin nodule (HP:0200036) | 2.78842737 |
| 90 | Thrombocytosis (HP:0001894) | 2.78335489 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.77933658 |
| 92 | Metabolic acidosis (HP:0001942) | 2.73498658 |
| 93 | Urticaria (HP:0001025) | 2.67974961 |
| 94 | Glomerulonephritis (HP:0000099) | 2.63832658 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.62891655 |
| 96 | Acanthocytosis (HP:0001927) | 2.59133588 |
| 97 | Vascular calcification (HP:0004934) | 2.59040829 |
| 98 | Lethargy (HP:0001254) | 2.57383931 |
| 99 | Cellulitis (HP:0100658) | 2.54159370 |
| 100 | Loss of speech (HP:0002371) | 2.53532276 |
| 101 | Leukocytosis (HP:0001974) | 2.53366068 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53181849 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.53181849 |
| 104 | Abnormal gallbladder morphology (HP:0012437) | 2.48364723 |
| 105 | Episodic fever (HP:0001954) | 2.47288416 |
| 106 | Increased cerebral lipofuscin (HP:0011813) | 2.46671083 |
| 107 | Viral hepatitis (HP:0006562) | 2.45732564 |
| 108 | Hypoglycemic seizures (HP:0002173) | 2.45162085 |
| 109 | Mitral stenosis (HP:0001718) | 2.45039715 |
| 110 | Spastic diplegia (HP:0001264) | 2.44488770 |
| 111 | T lymphocytopenia (HP:0005403) | 2.42523271 |
| 112 | Cholelithiasis (HP:0001081) | 2.41851649 |
| 113 | Cerebral edema (HP:0002181) | 2.39106275 |
| 114 | Amyloidosis (HP:0011034) | 2.38072944 |
| 115 | Joint swelling (HP:0001386) | 2.37984461 |
| 116 | Gout (HP:0001997) | 2.37929963 |
| 117 | Abnormality of T cells (HP:0002843) | 2.37661146 |
| 118 | Irritability (HP:0000737) | 2.34839662 |
| 119 | Neonatal onset (HP:0003623) | 2.33932828 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 2.33482168 |
| 121 | Cholecystitis (HP:0001082) | 2.33482168 |
| 122 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32956919 |
| 123 | Mucopolysacchariduria (HP:0008155) | 2.31940931 |
| 124 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31940931 |
| 125 | Gingival bleeding (HP:0000225) | 2.30849412 |
| 126 | Cardiovascular calcification (HP:0011915) | 2.29750267 |
| 127 | Abnormality of the endocardium (HP:0004306) | 2.26993791 |
| 128 | Hepatosplenomegaly (HP:0001433) | 2.26467340 |
| 129 | Anorexia (HP:0002039) | 2.25928488 |
| 130 | Abnormal platelet function (HP:0011869) | 2.25597477 |
| 131 | Impaired platelet aggregation (HP:0003540) | 2.25597477 |
| 132 | Esophageal varix (HP:0002040) | 2.24890625 |
| 133 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24773704 |
| 134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24773704 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24773704 |
| 136 | Malnutrition (HP:0004395) | 2.22995445 |
| 137 | Increased IgM level (HP:0003496) | 2.21734602 |
| 138 | Menorrhagia (HP:0000132) | 2.21491097 |
| 139 | Abnormality of T cell number (HP:0011839) | 2.20698365 |
| 140 | Abnormality of T cell physiology (HP:0011840) | 2.17612003 |
| 141 | Vertigo (HP:0002321) | 2.17564858 |
| 142 | Thrombophlebitis (HP:0004418) | 2.17218518 |
| 143 | Granulocytopenia (HP:0001913) | 2.16590931 |
| 144 | Increased serum ferritin (HP:0003281) | 2.15495899 |
| 145 | Osteomyelitis (HP:0002754) | 2.14251072 |
| 146 | Pancreatitis (HP:0001733) | 2.11598422 |
| 147 | Abnormality of the pleura (HP:0002103) | 2.11277861 |
| 148 | Late onset (HP:0003584) | 2.10921926 |
| 149 | Sensorimotor neuropathy (HP:0007141) | 2.10602019 |
| 150 | Brushfield spots (HP:0001088) | 2.09429776 |
| 151 | Enlarged kidneys (HP:0000105) | 2.08452987 |
| 152 | Gangrene (HP:0100758) | 2.07506918 |
| 153 | Poikilocytosis (HP:0004447) | 2.06442569 |
| 154 | Vomiting (HP:0002013) | 2.04182561 |
| 155 | Peritonitis (HP:0002586) | 2.03078306 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 2.02025661 |
| 157 | Hemorrhage of the eye (HP:0011885) | 2.01489481 |
| 158 | Opisthotonus (HP:0002179) | 2.00903970 |
| 159 | Abnormality of the gallbladder (HP:0005264) | 2.00851415 |
| 160 | Hypertensive crisis (HP:0100735) | 2.00180006 |
| 161 | Hypergammaglobulinemia (HP:0010702) | 1.99738688 |
| 162 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98797885 |
| 163 | Generalized aminoaciduria (HP:0002909) | 1.97817163 |
| 164 | Polyneuropathy (HP:0001271) | 1.96385896 |
| 165 | Cheilitis (HP:0100825) | 1.96358873 |
| 166 | Abnormality of iron homeostasis (HP:0011031) | 1.93725532 |
| 167 | Rickets (HP:0002748) | 1.92723086 |
| 168 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.91484236 |
| 169 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89593163 |
| 170 | Skin ulcer (HP:0200042) | 1.89555132 |
| 171 | Abnormal cartilage morphology (HP:0002763) | 1.85886702 |
| 172 | Abnormality of the peritoneum (HP:0002585) | 1.85845891 |
| 173 | Acrocyanosis (HP:0001063) | 1.85395151 |
| 174 | Nephritis (HP:0000123) | 1.85100464 |
| 175 | Hypophosphatemic rickets (HP:0004912) | 1.84708650 |
| 176 | Chronic otitis media (HP:0000389) | 1.84570384 |
| 177 | Sepsis (HP:0100806) | 1.84442140 |
| 178 | Xerostomia (HP:0000217) | 1.83084904 |
| 179 | Keratitis (HP:0000491) | 1.82857323 |
| 180 | Pustule (HP:0200039) | 1.82466859 |
| 181 | Renal cortical cysts (HP:0000803) | 1.82309312 |
| 182 | Arthralgia (HP:0002829) | 1.81713764 |
| 183 | Hydroxyprolinuria (HP:0003080) | 1.81276569 |
| 184 | Abnormality of proline metabolism (HP:0010907) | 1.81276569 |
| 185 | Elevated hepatic transaminases (HP:0002910) | 1.81109857 |
| 186 | Status epilepticus (HP:0002133) | 1.79587021 |
| 187 | Alkalosis (HP:0001948) | 1.79370662 |
| 188 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78651437 |
| 189 | Pulmonary embolism (HP:0002204) | 1.75698085 |
| 190 | Reticulocytosis (HP:0001923) | 1.72726679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.19613314 |
| 2 | RIPK4 | 5.01270590 |
| 3 | FGFR4 | 4.66071629 |
| 4 | SIK1 | 4.62521119 |
| 5 | ERN1 | 4.34821817 |
| 6 | BLK | 3.77103588 |
| 7 | TAOK3 | 3.05593206 |
| 8 | INSRR | 2.96854495 |
| 9 | ERBB4 | 2.86671234 |
| 10 | JAK3 | 2.71598578 |
| 11 | PRPF4B | 2.59085277 |
| 12 | MAP4K1 | 2.51832632 |
| 13 | TNK2 | 2.45177600 |
| 14 | MAP2K4 | 2.37097311 |
| 15 | PKN2 | 2.31847827 |
| 16 | FES | 2.11356060 |
| 17 | MST1R | 2.08221550 |
| 18 | ZAP70 | 1.97883948 |
| 19 | FLT3 | 1.93523890 |
| 20 | MAPK11 | 1.90925899 |
| 21 | MATK | 1.89975166 |
| 22 | CDC42BPA | 1.79605755 |
| 23 | TYK2 | 1.78976334 |
| 24 | TRIB3 | 1.77572824 |
| 25 | PIK3CG | 1.76171073 |
| 26 | KIT | 1.67788533 |
| 27 | FGR | 1.67286745 |
| 28 | SYK | 1.65738421 |
| 29 | DAPK2 | 1.62378300 |
| 30 | BTK | 1.58819599 |
| 31 | LATS1 | 1.52999184 |
| 32 | PTK6 | 1.48308791 |
| 33 | HCK | 1.47060753 |
| 34 | ABL2 | 1.46504470 |
| 35 | KDR | 1.46045475 |
| 36 | IRAK4 | 1.41996322 |
| 37 | FGFR2 | 1.40207802 |
| 38 | NEK9 | 1.33944284 |
| 39 | FRK | 1.33556447 |
| 40 | SMG1 | 1.27387607 |
| 41 | JAK2 | 1.26742728 |
| 42 | NME1 | 1.25642826 |
| 43 | LCK | 1.21502855 |
| 44 | SIK2 | 1.17802268 |
| 45 | MAP3K7 | 1.17707605 |
| 46 | LYN | 1.14855055 |
| 47 | PINK1 | 1.13376568 |
| 48 | GRK6 | 1.11834842 |
| 49 | PRKAA2 | 1.11004094 |
| 50 | TBK1 | 1.08169322 |
| 51 | MAP2K3 | 1.07755440 |
| 52 | TEC | 1.07417051 |
| 53 | JAK1 | 1.05714541 |
| 54 | MAP3K10 | 1.05334757 |
| 55 | MAPK4 | 1.02969591 |
| 56 | ERBB2 | 1.02464251 |
| 57 | BRD4 | 1.02460877 |
| 58 | MAP3K14 | 0.96566136 |
| 59 | IKBKB | 0.95182795 |
| 60 | TAOK1 | 0.94252125 |
| 61 | MARK2 | 0.94149995 |
| 62 | PRKD2 | 0.93123660 |
| 63 | TXK | 0.92975625 |
| 64 | PRKCZ | 0.91825599 |
| 65 | EPHB1 | 0.90254088 |
| 66 | SIK3 | 0.89784201 |
| 67 | MAPK12 | 0.86515797 |
| 68 | MET | 0.82457647 |
| 69 | TIE1 | 0.82263644 |
| 70 | EPHA3 | 0.82258291 |
| 71 | MAP3K3 | 0.81052513 |
| 72 | CDK6 | 0.80868861 |
| 73 | KSR2 | 0.77956113 |
| 74 | PRKACG | 0.77614585 |
| 75 | YES1 | 0.76842622 |
| 76 | STK38L | 0.76486425 |
| 77 | MAP3K11 | 0.76274722 |
| 78 | CDK12 | 0.76023241 |
| 79 | FYN | 0.73371589 |
| 80 | TGFBR2 | 0.73353882 |
| 81 | CSK | 0.72804774 |
| 82 | MAPK15 | 0.72774210 |
| 83 | DYRK1B | 0.70284815 |
| 84 | CAMK2G | 0.69864517 |
| 85 | CAMK1D | 0.69857235 |
| 86 | GSK3A | 0.65446359 |
| 87 | MARK3 | 0.65128464 |
| 88 | MAP2K6 | 0.65055656 |
| 89 | RIPK1 | 0.64795002 |
| 90 | MAP3K2 | 0.64752590 |
| 91 | PRKAA1 | 0.64226511 |
| 92 | ITK | 0.63562445 |
| 93 | SGK3 | 0.61520030 |
| 94 | FGFR3 | 0.60028148 |
| 95 | CSF1R | 0.59616559 |
| 96 | MAPK7 | 0.58583537 |
| 97 | IKBKE | 0.57688348 |
| 98 | EPHA4 | 0.52756535 |
| 99 | PTK2 | 0.52740228 |
| 100 | IRAK3 | 0.51869514 |
| 101 | CAMKK1 | 0.51796386 |
| 102 | CSNK1G1 | 0.51634859 |
| 103 | PRKCQ | 0.51614392 |
| 104 | PDPK1 | 0.50200677 |
| 105 | GRK1 | 0.46814784 |
| 106 | LRRK2 | 0.46506769 |
| 107 | RPS6KL1 | 0.46405968 |
| 108 | RPS6KC1 | 0.46405968 |
| 109 | BMPR2 | 0.45706728 |
| 110 | RET | 0.45010068 |
| 111 | IGF1R | 0.44872107 |
| 112 | SGK2 | 0.43894892 |
| 113 | TAOK2 | 0.43567968 |
| 114 | STK10 | 0.42775859 |
| 115 | MAP3K13 | 0.42392660 |
| 116 | PKN1 | 0.42119090 |
| 117 | CDK4 | 0.42034053 |
| 118 | PRKCG | 0.41664070 |
| 119 | MAP3K5 | 0.41250533 |
| 120 | PTK2B | 0.39780811 |
| 121 | MAP2K1 | 0.39005946 |
| 122 | CDK19 | 0.38957061 |
| 123 | RPS6KA6 | 0.38428239 |
| 124 | PRKD1 | 0.37822775 |
| 125 | ICK | 0.37361065 |
| 126 | STK24 | 0.37029848 |
| 127 | MAPKAPK2 | 0.36522193 |
| 128 | MAP3K6 | 0.36399817 |
| 129 | STK38 | 0.35548038 |
| 130 | EGFR | 0.34296348 |
| 131 | CAMK4 | 0.34080326 |
| 132 | PDGFRB | 0.33797538 |
| 133 | HIPK2 | 0.33317271 |
| 134 | PDK1 | 0.32928046 |
| 135 | MTOR | 0.32907208 |
| 136 | CSNK1G2 | 0.32373815 |
| 137 | RPS6KA2 | 0.32325312 |
| 138 | PBK | 0.30800515 |
| 139 | CSNK1G3 | 0.29980194 |
| 140 | CAMKK2 | 0.29902709 |
| 141 | SGK494 | 0.29639969 |
| 142 | SGK223 | 0.29639969 |
| 143 | PRKCA | 0.26063640 |
| 144 | MAP3K1 | 0.23355168 |
| 145 | IRAK1 | 0.22673454 |
| 146 | CAMK1G | 0.22065019 |
| 147 | LATS2 | 0.21465774 |
| 148 | CSNK1A1L | 0.21060549 |
| 149 | ABL1 | 0.21029712 |
| 150 | PIK3CA | 0.20636071 |
| 151 | IRAK2 | 0.20385407 |
| 152 | BMX | 0.20005768 |
| 153 | PAK3 | 0.19189651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.53244362 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62734139 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38769009 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36609542 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 3.23307738 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08204250 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85779072 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.77248490 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74439682 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.73835208 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67353086 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62311152 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61312245 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.57588229 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52788842 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47726998 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36309306 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32000680 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25100972 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.16637819 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14615734 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13005791 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 2.07278878 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06891964 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 2.06836073 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01641555 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95711910 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93121333 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92686296 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92676493 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92407629 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91067470 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90720815 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89081026 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88377558 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87117940 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.86211319 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85836723 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.82440845 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81239396 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77862931 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76765216 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74774582 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74436699 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74208157 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70955231 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69375072 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.69327950 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68670599 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 1.67042463 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65683646 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62116039 |
| 53 | Measles_Homo sapiens_hsa05162 | 1.61199185 |
| 54 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57408067 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56446414 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53452591 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.53209670 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50196986 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.50040297 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49618016 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49545993 |
| 62 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42529830 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40570696 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.37177991 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34845303 |
| 66 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33987428 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33422444 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32960702 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32770082 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31155968 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28869040 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28272777 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27416974 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22124508 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 1.20837308 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20442413 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19531052 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17988685 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 1.17537966 |
| 80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16242104 |
| 81 | Malaria_Homo sapiens_hsa05144 | 1.12909072 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11348250 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 1.10392901 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03804051 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02798709 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02495778 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01249765 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99886678 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99408823 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99333949 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98514713 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95964425 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95366012 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94524882 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93364305 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88657951 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.87940217 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87753802 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87015939 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86508311 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86291300 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85917171 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.84304368 |
| 104 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84275362 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82552855 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.80436521 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75790455 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75626497 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75175380 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74264981 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.71506922 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.70901115 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68857273 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66427074 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66127542 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65744247 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65476208 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.64593766 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.64268226 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62905414 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62871129 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.62849210 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.58145385 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58093664 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57780761 |
| 126 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56543648 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56310026 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55241559 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54842572 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54066439 |
| 131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53401350 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53278550 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51997866 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50749469 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45754427 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45242188 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42188494 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41391239 |
| 139 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41097070 |
| 140 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40237081 |
| 141 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39312377 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38565889 |
| 143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38529745 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38347667 |
| 145 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38018824 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36589103 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.35402051 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33834899 |
| 149 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31515112 |
| 150 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29681631 |
| 151 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29236323 |
| 152 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29044424 |
| 153 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29017566 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24920017 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24076722 |
| 156 | Insulin resistance_Homo sapiens_hsa04931 | 0.23175229 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22351132 |
| 158 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21869294 |
| 159 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21556735 |
| 160 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19894740 |
| 161 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14963680 |
| 162 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09612508 |
| 163 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01549697 |
| 164 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2488065 |
| 165 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2416985 |
| 166 | Amoebiasis_Homo sapiens_hsa05146 | -0.2408952 |
| 167 | Pertussis_Homo sapiens_hsa05133 | -0.2393344 |
| 168 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2247014 |
| 169 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2034228 |
| 170 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1954893 |
| 171 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1781786 |
| 172 | Hepatitis C_Homo sapiens_hsa05160 | -0.1781211 |
| 173 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1721329 |
| 174 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1625557 |
| 175 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1600786 |
| 176 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1574711 |
| 177 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1507989 |
| 178 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1322155 |
| 179 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1308100 |
| 180 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1050201 |
| 181 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0935801 |
| 182 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0900075 |
| 183 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0723757 |
| 184 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0498272 |

